Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023
The Journal of Infectious Diseases · 16.12.2024 · 230 (6) · 1410-1421
DOI: 10.1093/infdis/jiae303 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 27.08.2024. Verfasst von Jingrong Ye und 59 weiteren Autor:innen. Beteiligte Einrichtung: Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Beijing Academy of Preventive Medicin…. Hauptthemen laut MEDLINE: Drug Resistance, Viral, HIV Infections, Mutation, Anti-HIV Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Beijing Municipal Health Commission, China Capital's, Funds for Health Improvement and Research.
Abstract (Originalsprache)
Background
National treatment guidelines of China evolving necessitates population-level surveillance of transmitted drug resistance (TDR) to inform or update HIV treatment strategies.
Methods
We analyzed the demographic, clinical, and virologic data obtained from people with HIV (PWH) residing in 31 provinces of China who were newly diagnosed between 2018 and 2023. Evidence of TDR was defined by the World Health Organization list for surveillance of drug resistance mutations.
Results
Among the 22 124 PWH with protease and reverse transcriptase sequences, 965 (4.36%; 95% CI, 4.1–4.63) had at least 1 TDR mutation. The most frequent TDR mutations were nonnucleoside reverse transcriptase inhibitor (NNRTI) mutations (2.39%; 95% CI, 2.19%–2.59%), followed by nucleoside reverse transcriptase inhibitor mutations(1.35%; 95% CI, 1.2%–1.5%) and protease inhibitor mutations (1.12%; 95% CI, .98%–1.26%). The overall protease and reverse transcriptase TDR increased significantly from 4.05% (95% CI, 3.61%–4.52%) in 2018 to 5.39% (95% CI, 4.33%–6.57%) in 2023. A low level of integrase strand transfer inhibitor TDR was detected in 9 (0.21%; 95% CI, .1%–.38%) of 4205 PWH.
Conclusions
Presently, the continued use of NNRTI-based first-line antiretroviral therapy regimen for HIV treatment has been justified.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control (CDC), Beijing Academy of Preventive Medicine, Beijing.
- Division of Tuberculosis and HIV/AIDS Prevention, Shanghai CDC, Shanghai.
- Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou.
- Institute of AIDS/STD Control and Prevention, Jiangsu CDC, Nanjing.
- Center for Translational Medicine, Affiliated Infectious Diseases Hospital of Zhengzhou University (Henan Infectious Diseases Hospital, The Sixth People's Hospital of Zhengzhou), Zhengzhou.
- Center for AIDS/STD Control and Prevention, Sichuan CDC, Chengdu.
ORCID-Profile: Jingrong Ye, Yuan Dong, Jing Chen, Jinjin Liu, Xinli Lu, Weigui Guo, Minna Zheng, Hong Yang, Xiao Song, Cong Liu, Quanhua Zhou, Chenli Zheng, Qi Guo, Zhangwen Ge, Mingqiang Hao, Jianjun Li, Qiang Chen, Zhen Ning, Xuangu Liu, Jianyun Bai, Ya Gao, Xue Tong, Kangping Zhou, Ruijuan Qiao, Xiaojie Huang, Juan Wang, Xin Shen, Fengyu Hu, Aixia Tu, Guolong Yu, Shufang He, Xinhui Zhang, Conghui Xu
Förderung
- Beijing Municipal Health Commission
- China Capital's
- Funds for Health Improvement and Research
- Chinese Association of STD and AIDS Prevention and Control
- Liangshan Prefecture "Three Lines and One Network Bottom" Capacity Building Open Small Funding Project
- Guangzhou Municipal Science and Technology Bureau
- Science and Technology Project of Guangzhou
- Bureau of Beihai City Science and Technology
Zitieren
APA
Ye, J., Dong, Y., Lan, Y., Chen, J., Zhou, Y., Liu, J., Yuan, D., Lu, X., Guo, W., Zheng, M., Yang, H., Song, X., Liu, C., Zhou, Q., Zheng, C., Guo, Q., Yang, X., Zhang, L., Ge, Z., …, & Xu, C. (2024). Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023. The Journal of Infectious Diseases, 230(6), 1410-1421. https://doi.org/10.1093/infdis/jiae303
Vancouver
Ye J, Dong Y, Lan Y, Chen J, Zhou Y, Liu J, et al. Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023. The Journal of Infectious Diseases. 2024;230(6):1410-1421. doi:10.1093/infdis/jiae303
BibTeX
@article{Ye2024,
author = {Ye, Jingrong and Dong, Yuan and Lan, Yun and Chen, Jing and Zhou, Ying and Liu, Jinjin and Yuan, Dan and Lu, Xinli and Guo, Weigui and Zheng, Minna and Yang, Hong and Song, Xiao and Liu, Cong and Zhou, Quanhua and Zheng, Chenli and Guo, Qi and Yang, Xiaohui and Zhang, Lincai and Ge, Zhangwen and Liu, Lifeng and Yu, Fengting and Han, Yang and Huang, Huihuang and Hao, Mingqiang and Ruan, Yuhua and Wu, Jianjun and Li, Jianjun and Chen, Qiang and Ning, Zhen and Ling, Xuemei and Zhou, Chang and Liu, Xuangu and Bai, Jianyun and Gao, Ya and Tong, Xue and Zhou, Kangping and Mei, Fanghua and Yang, Zhengrong and Wang, Ao and Wei, Wei and Qiao, Ruijuan and Luo, Xinhua and Huang, Xiaojie and Wang, Juan and Shen, Xin and Hu, Fengyu and Zhang, Linglin and Tan, Wei and Fan, Jixiang and Tu, Aixia and Yu, Guolong and Fang, Yong and He, Shufang and Chen, Xin and Wu, Donglin and Zhang, Xinhui and Xin, Ruolei and He, Xin and Ren, Xianlong and Xu, Conghui},
title = {Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {230},
number = {6},
pages = {1410--1421},
doi = {10.1093/infdis/jiae303}
}
EUVIMED